Aristo Bio-tech An
NSE: ARISTO-SM
NSE
94.95
-0.05 (-0.05%)
Prev Close
95
Open Price
94.95
Volume
800
Today Low / High
94.95 / 94.95
52 WK Low / High
94.95 / 94.95
Range
90 - 100
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 94.95, with a change of -0.05 (-0.05263158%). The expected target range on the NSE is between 90 - 100. The stock is experiencing a downward trend on the NSE. Investors should be cautious as the price is currently declining.
25 Feb
94.95
0.00%
23 Feb
95.00
0.00%
19 Feb
90.15
8.71%
18 Feb
90.75
4.52%
13 Feb
90.75
0.00%
12 Feb
90.00
0.83%
11 Feb
93.45
-7.49%
10 Feb
86.30
3.13%
02 Feb
92.80
-3.77%
01 Feb
94.05
-0.05%
30 Jan
98.80
0.00%
Aristo Bio-tech An Graph
Aristo Bio-tech An Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Aristo Bio-tech An T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 94.95, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 94.95 | 95.90 | 86.31 - 105.49 |
| 96.85 | 77.48 - 116.22 | ||
| 97.80 | 68.46 - 127.14 | ||
| Bearish Scenario | 94.95 | 94.00 | 84.60 - 103.40 |
| 93.05 | 74.44 - 111.66 | ||
| 92.10 | 64.47 - 119.73 |
Overview of Aristo Bio-tech An
ISIN
INE082101010
Industry
Chemicals
Vol.Avg
4,224
Market Cap
0
Last Dividend
0.5
Official Website
IPO Date
2023-01-01
DCF Diff
44.92
DCF
50
Financial Ratios Every Investor Needs
Stock Dividend of ARISTO-SM
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-09-01 | September 01, 25 | 0.5 | 0.5 | 2025-09-01 | 2025-10-07 | |
| 2024-09-13 | September 13, 24 | 0.4 | 0.4 | 2024-09-13 | 2024-10-19 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 318.09 Cr | 295.85 Cr | 22.24 Cr | 0.0699 | 0.00 Cr | 4.13 Cr | 18.10 Cr | 4.06 Cr | 5.97 | 9.48 Cr | 0.0128 |
| 2024-03-31 | 245.15 Cr | 226.04 Cr | 19.11 Cr | 0.0780 | 0.00 Cr | 3.70 Cr | 15.38 Cr | 3.90 Cr | 5.72 | 8.56 Cr | 0.0159 |
| 2023-03-31 | 217.86 Cr | 196.00 Cr | 21.86 Cr | 0.1003 | 0.00 Cr | 5.82 Cr | 16.01 Cr | 3.56 Cr | 6.72 | 8.79 Cr | 0.0164 |
| 2022-03-31 | 165.76 Cr | 147.20 Cr | 18.56 Cr | 0.1120 | 0.00 Cr | 5.39 Cr | 13.17 Cr | 1.43 Cr | 2.87 | 5.23 Cr | 0.0086 |
| 2021-03-31 | 167.22 Cr | 150.15 Cr | 17.07 Cr | 0.1021 | 0.00 Cr | 3.63 Cr | 13.44 Cr | 1.08 Cr | 2.15 | 4.34 Cr | 0.0064 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 4.30 Cr | 140.62 Cr | 103.29 Cr | 37.3313 Cr | 21.85 Cr | 17.56 Cr | 47.37 Cr | 23.95 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 95.5758 Cr |
| 2024-03-31 | 5.41 Cr | 127.29 Cr | 93.68 Cr | 33.6086 Cr | 20.88 Cr | 15.46 Cr | 40.19 Cr | 21.68 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 83.5682 Cr |
| 2023-03-31 | 3.80 Cr | 99.83 Cr | 69.67 Cr | 30.1554 Cr | 22.49 Cr | 18.69 Cr | 30.78 Cr | 16.72 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 59.4856 Cr |
| 2022-03-31 | 2.60 Cr | 77.00 Cr | 62.14 Cr | 14.8657 Cr | 25.48 Cr | 22.88 Cr | 24.36 Cr | 14.46 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 50.9393 Cr |
| 2021-03-31 | 0.11 Cr | 81.42 Cr | 68.04 Cr | 13.3808 Cr | 22.25 Cr | 22.14 Cr | 31.95 Cr | 12.31 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 55.9727 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 10.0167 Cr | -5.1468 Cr | -4.3914 Cr | 4.9102 Cr | 0.4784 Cr | 1.1155 Cr | -5.1065 Cr | 4.0631 Cr | -2.3564 Cr | -0.3404 Cr | -7.1791 Cr |
| 2024-03-31 | 7.6004 Cr | -6.6096 Cr | -2.2066 Cr | 1.0455 Cr | -1.2158 Cr | 0.6371 Cr | -6.5549 Cr | 3.8957 Cr | -0.1696 Cr | -0.4425 Cr | -9.4095 Cr |
| 2023-03-31 | -2.7836 Cr | -3.7456 Cr | 7.9657 Cr | -6.8441 Cr | 1.4365 Cr | 1.8529 Cr | -4.0605 Cr | 3.5622 Cr | -0.9251 Cr | 0.0000 Cr | -6.4152 Cr |
| 2022-03-31 | 6.7781 Cr | -3.1601 Cr | -3.3138 Cr | 3.5293 Cr | 0.3041 Cr | 0.4164 Cr | -3.2488 Cr | 1.4338 Cr | -0.9689 Cr | 0.0000 Cr | 7.5833 Cr |
| 2021-03-31 | 2.2841 Cr | -1.9778 Cr | -0.7191 Cr | 0.2948 Cr | -0.4128 Cr | 0.1123 Cr | -1.9893 Cr | 1.0757 Cr | 1.3891 Cr | 0.0000 Cr | -7.6214 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 103.95 Cr | 98.49 Cr | 5.46 Cr | 0.0525 | 3.25 Cr | -0.49 Cr | -0.72 | 1.33 Cr | -0.0047 |
| 2024-09-30 | 214.15 Cr | 197.36 Cr | 16.79 Cr | 0.0784 | 14.86 Cr | 4.55 Cr | 6.70 | 8.15 Cr | 0.0213 |
| 2024-03-31 | 112.32 Cr | 103.82 Cr | 7.72 Cr | 0.0687 | 13.81 Cr | 1.32 Cr | 1.94 | 3.32 Cr | 0.0118 |
| 2023-09-30 | 132.83 Cr | 121.90 Cr | 10.93 Cr | 0.0823 | 4.47 Cr | 2.57 Cr | 3.78 | 5.24 Cr | 0.0194 |
| 2023-03-31 | 88.78 Cr | 78.99 Cr | 9.79 Cr | 0.1103 | 2.89 Cr | 0.97 Cr | 1.74 | 3.71 Cr | 0.0110 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 4.30 Cr | 0.00 Cr | 4.30 Cr | 56.18 Cr | 47.37 Cr | 115.76 Cr | 23.95 Cr | 140.62 Cr | 103.29 Cr |
| 2024-09-30 | 0.78 Cr | 0.00 Cr | 0.78 Cr | 142.27 Cr | 44.71 Cr | 199.45 Cr | 23.18 Cr | 223.28 Cr | 185.12 Cr |
| 2024-03-31 | 5.41 Cr | 0.00 Cr | 5.41 Cr | 57.47 Cr | 40.19 Cr | 105.03 Cr | 21.68 Cr | 127.29 Cr | 93.68 Cr |
| 2023-09-30 | 0.73 Cr | 0.00 Cr | 0.73 Cr | 75.31 Cr | 29.59 Cr | 109.91 Cr | 18.53 Cr | 128.44 Cr | 95.88 Cr |
| 2023-03-31 | 3.80 Cr | 0.00 Cr | 3.80 Cr | 44.57 Cr | 30.78 Cr | 83.10 Cr | 16.72 Cr | 99.83 Cr | 69.67 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -0.49 Cr | 4.85 Cr | -2.38 Cr | -2.13 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -2.09 Cr | 2.75 Cr |
| 2024-09-30 | 4.55 Cr | 5.17 Cr | -2.77 Cr | -2.26 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -3.01 Cr | 2.16 Cr |
| 2024-03-31 | 1.32 Cr | 4.53 Cr | -4.05 Cr | -0.57 Cr | -0.05 Cr | -0.05 Cr | -0.56 Cr | -3.97 Cr | 0.56 Cr |
| 2023-09-30 | 2.57 Cr | 3.07 Cr | -2.56 Cr | -1.64 Cr | -0.56 Cr | -0.56 Cr | 0.00 Cr | -2.59 Cr | 0.49 Cr |
| 2023-03-31 | 0.97 Cr | -5.57 Cr | -1.61 Cr | 7.72 Cr | 0.27 Cr | 0.27 Cr | 0.00 Cr | -1.83 Cr | -7.39 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Chemicals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Gujarat Fluorochemicals Limited | FLUOROCHEM | ₹3,494.50 | ₹383,870,825,000.00 | ₹66,028.00 |
| Navin Fluorine International Limited | NAVINFLUOR | ₹6,430.50 | ₹329,502,125,277.00 | ₹126,411.00 |
| Deepak Nitrite Limited | DEEPAKNTR | ₹1,581.70 | ₹215,732,872,950.00 | ₹45,615.00 |
| Tata Chemicals Limited | TATACHEM | ₹719.35 | ₹183,258,928,579.00 | ₹544,945.00 |
| Deepak Fertilisers And Petrochemicals Corporation Limited | DEEPAKFERT | ₹989.00 | ₹124,849,208,925.00 | ₹127,247.00 |
| Supreme Petrochem Limited | SPLPETRO | ₹646.65 | ₹121,596,933,804.00 | ₹23,520.00 |
| Archean Chemical Industries Limited | ACI | ₹590.15 | ₹72,858,971,219.00 | ₹121,347.00 |
| Gujarat Narmada Valley Fertilizers & Chemicals Limited | GNFC | ₹457.60 | ₹67,240,056,541.00 | ₹121,626.00 |
| India Glycols Limited | INDIAGLYCO | ₹928.50 | ₹62,234,351,303.00 | ₹36,476.00 |
| Rain Industries Limited | RAIN | ₹152.63 | ₹51,336,440,986.00 | ₹3,308,373.00 |
| GHCL Limited | GHCL | ₹480.95 | ₹44,215,753,490.00 | ₹151,571.00 |
| Meghmani Finechem Limited | MFL | ₹1,062.00 | ₹44,126,312,400.00 | ₹146,962.00 |
| Chemplast Sanmar Limited | CHEMPLASTS | ₹252.95 | ₹39,993,816,743.00 | ₹87,929.00 |
| Epigral Limited | EPIGRAL | ₹926.50 | ₹39,970,449,657.00 | ₹66,833.00 |
| Meghmani Organics Limited | MEGH | ₹139.00 | ₹35,285,704,610.00 | ₹5,511,910.00 |
| Gujarat Alkalies and Chemicals Limited | GUJALKALI | ₹477.30 | ₹35,051,445,734.00 | ₹20,250.00 |
| Styrenix Performance Materials Ltd. | STYRENIX | ₹1,919.90 | ₹33,762,641,438.00 | ₹10,662.00 |
| Ellenbarrie Industrial Gases Ltd | ELLEN | ₹234.75 | ₹33,084,632,100.00 | ₹206,680.00 |
| Raghav Productivity Enhancers Ltd. | RPEL | ₹711.85 | ₹32,682,428,726.00 | ₹19,974.00 |
| Foseco India Limited | FOSECOIND | ₹4,852.50 | ₹30,993,407,603.00 | ₹2,355.00 |
Key Executives
No executive data available.
FAQs about Aristo Bio-tech An
What is the current market price of the stock?
The current price is ₹94.95.
What is the 52-week price range?
The range is ₹94.95-94.95.
What is the dividend yield?
The dividend yield is 0.53%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 15.91.
Which sector does the company belong to?
The company operates in the Basic Materials sector.
What does the company do?
Overview of Aristo Bio-tech An (ISIN: INE082101010) is a leading Chemicals in India. With a market capitalization of ₹0.00 crores and an average daily volume of 4,224 shares, it operates in the Chemicals. The company last declared a dividend of ₹0.5.